e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
COPD exacerbation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Our experience of procalcitonin assay in identifying bacterial COPD exacerbations
C. Gough, P. Pillai, R. Mulla (Luton, United Kingdom)
Source:
Annual Congress 2011 - COPD exacerbation
Session:
COPD exacerbation
Session type:
Thematic Poster Session
Number:
571
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Gough, P. Pillai, R. Mulla (Luton, United Kingdom). Our experience of procalcitonin assay in identifying bacterial COPD exacerbations. Eur Respir J 2011; 38: Suppl. 55, 571
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Procalcitonin use in acute exacerbations of COPD
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Is CRP a reliable diagnostic tool for infective exacerbations of COPD?
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
C-reactive protein usefulness in diagnosis and follow-up of COPD infectious exacerbations
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
The role of procalcitonin as a marker of bacterial infection in COPD exacerbations requiring mechanical ventilation
Source: Annual Congress 2009 - Acute lung injury and biomarkers
Year: 2009
Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005
The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD
Source: Eur Respir J 2012; 40: 1344-1353
Year: 2012
C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD
Source: Eur Respir J 2015; 45: 76-86
Year: 2015
Sputum colour as a marker of acute bacterial exacerbations of COPD
Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations
Year: 2003
Is CRP really valid acute-phase inflammation reactant in all patients with sputum bacterial positive culture in acute exacerbation of COPD?
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019
Year: 2019
Sputum color as a marker for bacterial infection in severe acute exacerbations of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 240s
Year: 2004
Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1514-1515
Year: 2015
Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1515-1516
Year: 2015
An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation
Source: International Congress 2014 – Markers
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept